Sabra Health Care REIT, Inc. (SBRA)
USD 16.9
(-4.25%)
USD 16.9
(-4.25%)
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2023 | 418.15 Million USD | 29.32% |
| 2022 | 323.35 Million USD | 63.28% |
| 2021 | 166.21 Million USD | -52.62% |
| 2020 | 417.96 Million USD | -19.13% |
| 2019 | 516.86 Million USD | 2.33% |
| 2018 | 511.7 Million USD | 47.93% |
| 2017 | 353.92 Million USD | 42.24% |
| 2016 | 285.39 Million USD | 18.92% |
| 2015 | 277.91 Million USD | 29.6% |
| 2014 | 193.59 Million USD | 32.48% |
| 2013 | 33.28 Million USD | 31.7% |
| 2012 | 30.26 Million USD | 27.97% |
| 2011 | 26.59 Million USD | 2013.7% |
| 2010 | 7.24 Million USD | 0.0% |
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2024 Q1 | 103.55 Million USD | -11.0% |
| 2024 Q2 | 111.29 Million USD | 8.37% |
| 2024 Q3 | 72.77 Million USD | -6.52% |
| 2023 Q3 | 103.29 Million USD | 1.45% |
| 2023 Q2 | 101.81 Million USD | -0.89% |
| 2023 Q1 | 102.72 Million USD | 369.7% |
| 2023 FY | - USD | 29.32% |
| 2023 Q4 | 112.81 Million USD | 9.22% |
| 2022 Q4 | 21.87 Million USD | -74.6% |
| 2022 Q1 | 111.38 Million USD | 49.08% |
| 2022 FY | - USD | 63.28% |
| 2022 Q3 | 86.09 Million USD | -17.23% |
| 2022 Q2 | 104 Million USD | -6.62% |
| 2021 FY | - USD | -52.62% |
| 2021 Q4 | 74.71 Million USD | -7.02% |
| 2021 Q2 | -59.48 Million USD | -158.06% |
| 2021 Q3 | 80.35 Million USD | 235.09% |
| 2021 Q1 | 102.44 Million USD | -3.34% |
| 2020 Q4 | 105.98 Million USD | -0.02% |
| 2020 Q3 | 106.01 Million USD | 6.43% |
| 2020 FY | - USD | -19.13% |
| 2020 Q2 | 99.61 Million USD | -6.33% |
| 2020 Q1 | 106.34 Million USD | -11.19% |
| 2019 Q4 | 119.75 Million USD | 7.8% |
| 2019 FY | - USD | 2.33% |
| 2019 Q1 | 113.15 Million USD | 34.24% |
| 2019 Q2 | 176.98 Million USD | 56.42% |
| 2019 Q3 | 111.08 Million USD | -37.23% |
| 2018 Q2 | 143.06 Million USD | -3.43% |
| 2018 Q1 | 148.14 Million USD | 3.83% |
| 2018 Q4 | 84.29 Million USD | -33.85% |
| 2018 Q3 | 127.43 Million USD | -10.93% |
| 2018 FY | - USD | 47.93% |
| 2017 FY | - USD | 42.24% |
| 2017 Q4 | 142.68 Million USD | 59.82% |
| 2017 Q3 | 89.28 Million USD | 80.05% |
| 2017 Q2 | 49.58 Million USD | -7.69% |
| 2017 Q1 | 53.71 Million USD | -8.99% |
| 2016 FY | - USD | 18.92% |
| 2016 Q2 | 70.35 Million USD | 30.5% |
| 2016 Q3 | 56.75 Million USD | -19.32% |
| 2016 Q4 | 59.02 Million USD | 3.99% |
| 2016 Q1 | 53.91 Million USD | -6.02% |
| 2015 Q2 | 43.65 Million USD | -8.04% |
| 2015 FY | - USD | 29.6% |
| 2015 Q1 | 47.46 Million USD | 0.83% |
| 2015 Q3 | 53.35 Million USD | 22.23% |
| 2015 Q4 | 57.36 Million USD | 7.52% |
| 2014 Q1 | 35.29 Million USD | 9.86% |
| 2014 Q4 | 47.07 Million USD | 25.01% |
| 2014 Q3 | 37.65 Million USD | 5.46% |
| 2014 Q2 | 35.7 Million USD | 1.16% |
| 2014 FY | - USD | 32.48% |
| 2013 Q4 | 32.13 Million USD | 6.5% |
| 2013 Q1 | 27.8 Million USD | 7.07% |
| 2013 FY | - USD | 31.7% |
| 2013 Q2 | 27.45 Million USD | -1.27% |
| 2013 Q3 | 30.16 Million USD | 9.89% |
| 2012 Q2 | 21.62 Million USD | 11.45% |
| 2012 Q1 | 19.4 Million USD | -12.27% |
| 2012 Q3 | 22.26 Million USD | 2.92% |
| 2012 FY | - USD | 27.97% |
| 2012 Q4 | 25.96 Million USD | 16.66% |
| 2011 Q4 | 22.12 Million USD | 31.53% |
| 2011 Q2 | 15.88 Million USD | 6.38% |
| 2011 FY | - USD | 2013.7% |
| 2011 Q3 | 16.81 Million USD | 5.89% |
| 2011 Q1 | 14.93 Million USD | 345.83% |
| 2010 FY | - USD | 0.0% |
| 2010 Q4 | 3.34 Million USD | 0.0% |
| Name | EBITDA | EBITDA Difference |
|---|---|---|
| Diversified Healthcare Trust | 207.29 Million USD | -101.716% |
| Diversified Healthcare Trust | 207.29 Million USD | -101.716% |
| Healthcare Trust, Inc. | 81.13 Million USD | -415.363% |
| Healthcare Trust, Inc. | 81.13 Million USD | -415.363% |